Sauerbrey A, Zintl F, Volm M
University of Jena, Children's Hospital, Germany.
Br J Cancer. 1994 Dec;70(6):1144-9. doi: 10.1038/bjc.1994.462.
Blast cells obtained from 104 children with untreated acute lymphoblastic leukaemia were analysed for the expression of P-glycoprotein (P-170) and glutathione S-transfer pi (GST-pi) using immunohistochemistry. Expression of P-170 was detected in 36 of 104 patients (35%) and increased GST-pi was seen in 52 patients (50%). Coexpression of both resistance proteins was observed in 22 leukaemias (21%), whereas no evidence of the resistance markers was found in 38 cases (37%). In patients with P-170-positive leukaemic cells, a significantly lower probability of remaining in first continuous complete remission (CCR) was observed when compared with patients with P-170-negative tumours (P < 0.05). However, only a trend for a more frequent expression of P-170 was found in the leukaemic cells of patients who experienced relapses (P = 0.099). Overexpression of GST-pi was correlated with a higher relapse rate (P = 0.001) and a lower probability of remaining in first CCR (P = 0.01). Expression of P-170 and GST-pi was independent of sex, FAB type, immunological subtype and initial blast cell count. The multivariate analysis indicated that only the expression of P-170 is an unfavourable prognostic factor for children with acute lymphoblastic leukaemia in addition to the prognostic clinical factors.
采用免疫组织化学方法,对104例未经治疗的急性淋巴细胞白血病患儿的原始细胞进行P-糖蛋白(P-170)和谷胱甘肽S-转移酶π(GST-π)表达分析。104例患者中,36例(35%)检测到P-170表达,52例(50%)出现GST-π表达增加。22例白血病(21%)中观察到两种耐药蛋白的共表达,而38例(37%)未发现耐药标志物证据。与P-170阴性肿瘤患者相比,P-170阳性白血病细胞患者首次持续完全缓解(CCR)的概率显著降低(P<0.05)。然而,在复发患者的白血病细胞中仅发现P-170表达更频繁的趋势(P=0.099)。GST-π的过表达与较高的复发率(P=0.001)和首次CCR的较低概率(P=0.01)相关。P-170和GST-π的表达与性别、FAB分型、免疫亚型及初始原始细胞计数无关。多因素分析表明,除了预后临床因素外,仅P-170的表达是急性淋巴细胞白血病患儿不良的预后因素。